This review explores the evolution of lipid‐based nanoparticles (LBNPs) for drug delivery (DD). Herein, LBNPs are classified into liposomes and cell membrane‐based nanoparticles (CMNPs), each with unique advantages and challenges. Conventional LBNPs possess drawbacks such as poor targeting, quick clearance, and limited biocompatibility. One of the possible alternatives to overcome these challenges is surface modification of nanoparticles (NPs) with materials such as polyethylene glycol (PEG), aptamers, antibody fragments, peptides, CD44, hyaluronic acid, folic acid, palmitic acid, and lactoferrin. Thus, the main focus of this review will be on the different surface modifications that enable LBNPs to have beneficial properties for DD, such as enhancing mass transport properties, immune evasion, improved stability, and targeting. Moreover, various CMNPs are explored used for DD derived from cells such as red blood cells (RBCs), platelets, leukocytes, cancer cells, and stem cells, highlighting their unique natural properties (e.g., biocompatibility and ability to evade the immune system). This discussion extends to the biomimicking of hybrid NPs accomplished through the surface coating of synthetic (mainly polymeric) NPs with different cell membranes. This review aims to provide a comprehensive resource for researchers on recent advances in the field of surface modification of LBNPs and CMNPs. Overall, this review provides valuable insights into the dynamic field of lipid‐based DD systems.

Drug administration by oral delivery is the preferred route, regardless of some remaining challenges, such as short resident time and toxicity issues. One strategy to overcome these barriers is utilizing mucoadhesive vectors that can increase intestinal resident time and systemic uptake. In this study, biomimetic nanoparticles (NPs) were produced from 14 types of edible algae and evaluated for usage as oral DDSs by measuring their size, surface charge, morphology, encapsulation efficiency, mucoadhesion force, and cellular uptake into Caco-2 cells. The NPs composed of algal materials (aNPs) exhibited a spherical morphology with a size range of 126–606 nm and a surface charge of −9 to −38 mV. The mucoadhesive forces tested ex vivo against mice, pigs, and sheep intestines revealed significant variation between algae and animal models. Notably, Arthospira platensis (i.e., Spirulina) NPs (126 ± 2 nm, −38 ± 3 mV) consistently exhibited the highest mucoadhesive forces (up to 3127 ± 272 µN/mm²). Moreover, a correlation was found between high mucoadhesive force and high cellular uptake into Caco-2 cells, further supporting the potential of aNPs by indicating their ability to facilitate drug absorption into the human intestinal epithelium. The results presented herein serve as a proof of concept for the possibility of aNPs as oral drug delivery vehicles.

Background Commercialization of biosurfactant production is a big challenge due to high production cost. Biosurfactant production can be made economic by using low cost agro-industrial wastes or byproducts as media supplement. It also solves the problem of environmental pollution through waste management. In the present study attempt was made to produce biosurfactant from Sphingobacterium thalpophilum DP9 using various agro-industrial wastes or byproducts at optimum fermentation conditions evaluated by traditional and statistical methods. Partial characterization of biosurfactant was also carried out through qualitative chromatographic techniques; quantitative spectroscopic method and functional group identification by Fourier transform infrared spectroscopy. Results One factor at a time optimization experimentation showed highest emulsification in media supplemented with potato peel powder (43.12 ± 3.41%), urea (46.00 ± 3.09%), pH 7 (41.74 ± 1.15%) at 40% aeration (47.41 ± 1.62%). 1% Inoculum (O.D.₆₀₀=1.00) size favored highest emulsification (26.39 ± 1.60%). Plackett-Burman design experimentation showed carbon source (potato peel powder), nitrogen source (urea) and temperature significantly affect on biosurfactant production. Response surface experimentation by central composite design showed interaction between nitrogen source and temperature significantly influenced on biosurfactant production. Validation of model was showed increase in emulsification from 43.62 ± 2.55% to 86.11 ± 3.47% on fourth day of incubation. Partial characterization showed biosurfactant contains 439.58 ± 0.0129 µg/ml carbohydrate and 507.41 ± 0.0064 µg/ml of protein. Lipid was absent in it. Fourier transform infrared spectroscopy chromatogram showed peaks at 1652.17 cm^− 1, 1541.01 cm^− 1, 1463.71 cm^− 1 and 722.32 cm^− 1 which indicated presence of peptide bond, peptide moiety, carbohydrate protons and primary as well as secondary amines. Conclusion Potato peel powder, urea and temperature have significant influence on biosurfactant production from Sphingobacterium thalpophilum DP9. When potato peel powder and urea supplied at optimum level, biosurfactant production was increased by two fold. Biosurfactant produced by S. thalpophilum DP9 was belongs to glycoprotein class and as per our best knowledge, this is the first report on glycoprotein biosurfactant produced from Sphingobacterium genus.

Background: Hirudo granulosa—an Indian cattle leech, is frequently used for the treatment of psoriasis and eczema. During treatment which followed by leech biting, it transfers some amount of gut microbes along with saliva. This may result in bacterial infection at the treatment site. Antibiotics used as post-surgical hirudotherapy is the reason for drug resistance. Drug resistance is the result of the change in the genetic makeup of bacteria. Therefore, it is necessary to study antibiotic sensitivity of gut bacteria and characterized them genetically. Results: Fourteen bacterial isolates were obtained from unused leech in which five were Gram-negative and the other nine were Gram-positive. Similarly from the used leech, thirteen were isolated in which five were Gram-negative and the other eight were Gram-positive. Biochemical analysis reveals that isolates from unused leech saliva belong to Pseudomonas, Micrococcus, Streptococcus, and Vibrio species, while the used leech salivary bacteria were the member of genus Pseudomonas, Comamonas, Escherichia, Citrobacter, Aeromonas, Providencia, Enterobacter, and Yersinia. Antibiotic sensitivity tests for isolates indicated that chloramphenicol (30 μg) and norfloxacin (10 μg) were effective for unused leech isolates while sparfloxacin (5 μg) and Cefaclor (30 μg) were effective against used leech salivary isolates. Random primer (OPL-14)-based random amplified polymorphic DNA (RAPD) fingerprint showed twenty amplified regions among all tested bacteria. Most of the bacteria contain the tested sequence except U2, T2, T9A, and T10 which showed no amplification indicated the absence of primers sequence. Conclusion: Chloramphenicol, norfloxacin, sparfloxacin, and Cefaclor antibiotics alone or in combination were possibly used to treat post-therapy infections. Bacteria from treated and untreated leeches were clustered at nearby branch in neighbor end-joining phylogenetic tree, which indicates the similar (but not exact) genetic makeup. Therefore, it can be concluded that these antibiotics were possibly used against most of them.

Engineered Spirulina as a living, edible bioreactor and carrier: stable expression of bioactive human insulin, scalable production, and enhanced intestinal uptake—advancing a bioadhesive, noninvasive paradigm for oral protein delivery.